Results 211 to 220 of about 174,628 (339)

Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED‐AHF): A prospective, randomized, mechanistic study

open access: yesEuropean Journal of Heart Failure, EarlyView.
The impact of sodium chloride (NaCl) supplementation on proximal and distal tubular reabsorption in acute heart failure (AHF). Abstract Aims We questioned the long‐standing paradigm that sodium/chloride restriction is essential for effective decongestion in acute heart failure (AHF). This study compared the decongestive effects of two isotonic infusion
Jan Biegus   +7 more
wiley   +1 more source

Effects of Hormone Replacement Treatment with Estrogen and Progestins on the Vascular Renin-Angiotensin System of Ovariectomized Rats. [PDF]

open access: yesInt J Mol Sci
Menezes LA   +7 more
europepmc   +1 more source

Chronic Copper Overload Triggers Inflammation in Mesenteric PVAT Alongside Changes in Renin-Angiotensin System-Related Pathways. [PDF]

open access: yesNutrients
Mawandji NBS   +8 more
europepmc   +1 more source

Cardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the
Daniela Tomasoni   +17 more
wiley   +1 more source

Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub‐analysis of the EMPAG‐HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure)

open access: yesEuropean Journal of Heart Failure, EarlyView.
Effects of empagliflozin on uric acid levels during acute heart failure recompensation. Abstract Background Sodium–glucose cotransporter 2 inhibitors improve prognosis in chronic heart failure as part of currently recommended therapeutic strategies.
Jurgen Bogoviku   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy